The way to prevent physiological anemia piglets

 

(57) Abstract:

The invention relates to the field of veterinary medicine and can be used for prevention of physiological enumiii piglets. The objective of the invention is to achieve an appropriate level of hemoglobin in the blood of piglets from the first days of their life, which avoids physiological anemia and to reduce their susceptibility to other diseases. The task is solved in that in the method of prevention fiziologicheskii anemia pigs, comprising introducing into the animal organism in 3-7 days of age feroglobin dose of 120-160 mg of catalyst and synthesis of hemoglobin, as a catalyst for the synthesis of hemoglobin using iodine, and the introduction of it in the body carry out the method of implantation at a dose of 2-4 mg per animal. 1 Il., table 1.

The invention relates to the field of veterinary medicine and can be used for prevention of physiological anemia in piglets.

The known method of prevention of physiological anemia of pigs, including injection feroglobin dose of 140 - 160 mg per animal (veterinary drugs: a Handbook. Edited by D. F., Osize. M.: Kolos, 1981, page 221). The disadvantage of this method is low efficiency, visualsite erythrocytic cells), but only the original raw material) for the biosynthesis of hemoglobin.

The closest in technical essence is a way to prevent physiological anemia of pigs, including the introduction into the organism of the animal feroglobin and catalyst for the synthesis of hemoglobin, and ferrolysis enter in 3-7 days of age at a dose of 120-160 mg (N.With.Vasiliev. Prevention of nutritional anaemia pigs in conditions of Yakutia. Veterinary medicine No. 2, 1997, pp. 47 - 48).

The disadvantage of this method is that it is a long time in execution and has low efficiency.

The objective of the proposed invention is to achieve an appropriate level of hemoglobin in the blood of piglets from the first days of their life that will allow you to avoid physiological anemia in piglets and to reduce their susceptibility to other diseases.

The task is solved in that in the method of prevention of physiological anemia of pigs, including the introduction in the body of the animal in 3-7 days of age feroglobin dose of 120-160 mg of catalyst and synthesis of hemoglobin, as a catalyst for the synthesis of hemoglobin using iodine, and the introduction of it in the body carry out the method of implantation dose of 2 to 4 mg per LM is the such animal with ferroaluminum is a catalyst for the synthesis of hemoglobin, resulting in the synthesis of hemoglobin occurring in the required number of piglets after injection feroglobin, usually 28 to 30 day begins at 7 days.

The method is as follows. In three days of age pigs intramuscularly, feroglobin dose of 140 - 160 mg. Simultaneously once subcutaneously on the lateral surface of the ear implanted iodine dose of 2 to 4 mg.

The hemoglobin in the blood was determined at 7, 14, 21, 28 and 35 days after injection feroglobin and implantation of iodine.

In the figure below presents a diagram of the experience, and the graph shows the results.

Example 1. Took a group of 3-day-old piglets in the amount of 10 goals and have them injected feroglobin at a dose of 150 mg per head. Simultaneously on the lateral surfaces of the ear did puncture and was injected under the skin of potassium iodide tablets in the calculation of the iodine in the amount of 2 mg per head. Further dose reduction of iodine did not lead to a significant increase in hemoglobin in the first 20 days compared with the usual injection feroglobin.

Example 2. The group of piglets in the amount of 10 animals were injected feroglobin at a dose of 150 mg per head.

Simultaneously on the lateral powermodules increasing doses of iodine did not increase hemoglobin in the blood of the animal in the first 20 days.

The way to prevent physiological anemia of pigs, including an introduction to the animal organism in 3 to 7 days of age feroglobin dose of 120-160 mg of catalyst and synthesis of hemoglobin, wherein as catalyst for the synthesis of hemoglobin using iodine, and the introduction of it in the body carry out the method of implantation at a dose of 2 to 4 mg per animal.

 

Same patents:

The invention relates to the field of veterinary pharmacology and can be used for the prevention and treatment of hypochromic microcytic anemia

The invention relates to medicine and veterinary

The invention relates to livestock and can be used in pig production to replenish iodine deficiency in sows

The invention relates to the pharmaceutical industry, in particular, to methods of producing products with mineral filler with a specific type of release used in VETERINARII with bactericidal and wound-healing effect
The invention relates to biotechnology and can be used in the production of Baker's yeast, medical drugs, food and feed additives derived from yeast biomass
The invention relates to veterinary and zootechnique and can be used to improve productivity, therapy and prevention of metabolic substance in ewes, prevention of metabolic diseases in lambs
The invention relates to medicine, namely to dermatology, and relates to a method of topical treatment of fungal infections of the feet and smooth skin

The invention relates to the use of starch as a substance that forms a complex with iodine, for the learning of dry pharmaceutical compositions applicable in the form of capsules or tablets

The invention relates to the field of veterinary pharmacology and can be used for the prevention and treatment of hypochromic microcytic anemia

The invention relates to medicine, namely to dermatology, urology and gynecology

The invention relates to fur farming and animal husbandry

The invention relates to biologically active agents with antiproliferative and cytotoxic activity and can be used in pharmaceutical, chemical industries and medicine

The invention relates to new chemical compounds, specifically to derived TRANS-sodium dichloro(bromo)-bis{ gamma-1,2,5-trimethyl-4-(3,4-dimethyl-3,4 - dihydroxy-1-pentenyl)-4-piperidin this, N}Pt (II), General formula

< / BR>
where

X is Cl or Br;

- the remainder of the ligand-gamma 1,2,5-trimethyl-4-(3,4-dimethyl-3,4-dihydroxy-1-pentenyl)-4-piperidone,

showing antihelminthic activity

The invention relates to animal breeding and fur farming and can be used for the prevention and treatment of iron deficiency anemia and enhance the growth of fur-bearing animals, farm and domestic animals, as well as to maintain the microelemental composition of the feed

The invention relates to medicine, specifically to drug anti-TB drugs

Antianemic agent // 2079307
The invention relates to medicine and veterinary medicine, namely to the treatment and prevention of iron deficiency in humans and animals

FIELD: pharmaceutical engineering; medical engineering.

SUBSTANCE: method involves carrying out nuclear magnetic resonance tomography of human or animal blood circulation system containing chelating ion complexes of bivalent and valence three paramagnetic metals of (I)X-L-Y formula, where X is the polyamide carbonyl ligand residue and Y is the gallic acid derivative, .

EFFECT: high accuracy of diagnosis.

28 cl

Up!